Pendal Group Ltd Boosts Stock Holdings in Agilent Technologies Inc (NYSE:A)
Pendal Group Ltd boosted its stake in shares of Agilent Technologies Inc (NYSE:A) by 13.1% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,289,177 shares of the medical research company’s stock after acquiring an additional 149,241 shares during the period. Agilent Technologies accounts for 1.2% of Pendal Group Ltd’s portfolio, making the stock its 24th largest holding. Pendal Group Ltd owned approximately 0.41% of Agilent Technologies worth $84,300,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Stratos Wealth Partners LTD. boosted its stake in shares of Agilent Technologies by 2.7% during the 1st quarter. Stratos Wealth Partners LTD. now owns 31,792 shares of the medical research company’s stock worth $2,555,000 after purchasing an additional 850 shares during the period. Prentiss Smith & Co. Inc. boosted its stake in shares of Agilent Technologies by 484.9% during the 2nd quarter. Prentiss Smith & Co. Inc. now owns 58,428 shares of the medical research company’s stock worth $4,363,000 after purchasing an additional 48,438 shares during the period. TimesSquare Capital Management LLC boosted its stake in shares of Agilent Technologies by 0.7% during the 1st quarter. TimesSquare Capital Management LLC now owns 1,007,700 shares of the medical research company’s stock worth $80,999,000 after purchasing an additional 7,200 shares during the period. Nordea Investment Management AB boosted its stake in shares of Agilent Technologies by 510.5% during the 1st quarter. Nordea Investment Management AB now owns 112,292 shares of the medical research company’s stock worth $9,028,000 after purchasing an additional 93,898 shares during the period. Finally, Mason Street Advisors LLC boosted its stake in shares of Agilent Technologies by 0.8% during the 1st quarter. Mason Street Advisors LLC now owns 45,312 shares of the medical research company’s stock worth $3,642,000 after purchasing an additional 370 shares during the period.
A number of equities research analysts recently weighed in on the stock. Zacks Investment Research lowered shares of Agilent Technologies from a “hold” rating to a “sell” rating and set a $71.00 price objective for the company. in a report on Tuesday, July 16th. Wolfe Research assumed coverage on shares of Agilent Technologies in a report on Thursday, May 30th. They set a “peer perform” rating for the company. Deutsche Bank decreased their price objective on shares of Agilent Technologies from $90.00 to $85.00 and set a “buy” rating for the company in a report on Wednesday, May 15th. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Friday, July 12th. Finally, Barclays downgraded shares of Agilent Technologies from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $86.00 to $78.00 in a research report on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and ten have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $83.92.
Agilent Technologies (NYSE:A) last released its earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share for the quarter, missing the consensus estimate of $0.72 by ($0.01). The company had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.65 EPS. As a group, equities research analysts predict that Agilent Technologies Inc will post 3.05 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd were given a dividend of $0.164 per share. This represents a $0.66 annualized dividend and a yield of 0.96%. The ex-dividend date of this dividend was Monday, July 1st. Agilent Technologies’s dividend payout ratio is presently 23.66%.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Featured Article: What type of investment options does a Roth IRA provide?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.